AstraZeneca’s CCP virus vaccine is producing an encouraging immune response among both older and younger adults, the drugmaker said on Oct. 26. That puts the vaccine one step closer to being available in Canada.
The drugmaker said its COVID-19 vaccine produces a similar immune response in both old and young adults, and triggers lower adverse responses among the elderly during clinical trials.
